Patients with inoperable, early-stage lung cancer who receive stereotactic body radiation therapy have 40% five-year survival rate

16 September 2014

Patients with inoperable, early-stage lung cancer who receive stereotactic body radiation therapy (SBRT) have a five-year survival rate of 40 percent, according to new research.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/JsoBq5jCkyc/140916111721.htm